Reduction in Pseudomonas aeruginosa sputum density during a cystic fibrosis pulmonary exacerbation does not predict clinical response

被引：0
|
作者：
John C Lam
Ranjani Somayaji
Michael G Surette
Harvey R Rabin
Michael D Parkins
机构：
[1] The University of Calgary,Department of Medicine
[2] McMaster University,The Department of Microbiology, Immunology and Infectious Disease
[3] The University of Calgary,undefined
来源：
BMC Infectious Diseases | / 15卷
关键词：
Treatment; Biomarker; Failure; Outcome; Bronchiectasis; Cefepime; Heterogeneity;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Reduction in Pseudomonas aeruginosa sputum density during a cystic fibrosis pulmonary exacerbation does not predict clinical response
    Lam, John C.
    Somayaji, Ranjani
    Surette, Michael G.
    Rabin, Harvey R.
    Parkins, Michael D.
    BMC INFECTIOUS DISEASES, 2015, 15
  • [2] REDUCTION IN P. AERUGINOSA SPUTUM DENSITY DURING A PULMONARY EXACERBATION IN CYSTIC FIBROSIS DOES NOT PREDICT CLINICAL RESPONSE
    Lam, J.
    Rabin, H.
    Surette, M.
    Somayaji, R.
    Parkins, M.
    PEDIATRIC PULMONOLOGY, 2014, 49 : 250 - 250
  • [3] Does bacterial density in cystic fibrosis sputum increase prior to pulmonary exacerbation?
    Stressmann, Franziska A.
    Rogers, Geraint B.
    Marsh, Peter
    Lilley, Andrew K.
    Daniels, Thomas W. V.
    Carroll, Mary P.
    Hoffman, Lucas R.
    Jones, Graeme
    Allen, Collette E.
    Patel, Nilesh
    Forbes, Benjamin
    Tuck, Andrew
    Bruce, Kenneth D.
    JOURNAL OF CYSTIC FIBROSIS, 2011, 10 (05) : 357 - 365
  • [4] Daily variability of Pseudomonas aeruginosa density in cystic fibrosis sputum
    Carmody, Lisa A.
    Caverly, Lindsay J.
    Kalikin, Linda M.
    Thornton, Christina S.
    Simon, Richard H.
    Vandevanter, Donald R.
    Lipuma, John J.
    JOURNAL OF CYSTIC FIBROSIS, 2025, 24 (02) : 341 - 344
  • [5] Molecular analysis of changes in Pseudomonas aeruginosa load during treatment of a pulmonary exacerbation in cystic fibrosis
    Reid, D. W.
    Latham, R.
    Lamont, I. L.
    Camara, M.
    Roddam, L. F.
    JOURNAL OF CYSTIC FIBROSIS, 2013, 12 (06) : 688 - 699
  • [6] Energetic cost of physical activity in cystic fibrosis children during Pseudomonas aeruginosa pulmonary exacerbation
    Béghin, L
    Gottrand, F
    Michaud, L
    Vodougnon, H
    Wizla-Derambure, N
    Hankard, R
    Husson, MO
    Turck, D
    CLINICAL NUTRITION, 2005, 24 (01) : 88 - 96
  • [7] Tobromycin nebuliser solution in the treatment of cystic fibrosis pulmonary exacerbations:: Effect on sputum Pseudomonas aeruginosa density
    Al-Aloul, M
    Miller, H
    Ledson, MJ
    Walshaw, MJ
    THORAX, 2005, 60 : II92 - II92
  • [8] Sputum Desmosine During Hospital Admission for Pulmonary Exacerbation in Cystic Fibrosis
    Laguna, Theresa A.
    Wagner, Brandie D.
    Luckey, Heidi K.
    Mann, Shelley A.
    Sagel, Scott D.
    Regelmann, Warren
    Accurso, Frank J.
    CHEST, 2009, 136 (06) : 1561 - 1568
  • [9] Essential genome of Pseudomonas aeruginosa in cystic fibrosis sputum
    Turner, Keith H.
    Wessel, Aimee K.
    Palmer, Gregory C.
    Murray, Justine L.
    Whiteley, Marvin
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2015, 112 (13) : 4110 - 4115
  • [10] PSEUDOMONAS-AERUGINOSA ALGINATE IN CYSTIC-FIBROSIS SPUTUM AND THE INFLAMMATORY RESPONSE
    PEDERSEN, SS
    KHARAZMI, A
    ESPERSEN, F
    HOIBY, N
    INFECTION AND IMMUNITY, 1990, 58 (10) : 3363 - 3368
12345